Mr. Adam Kelliher was appointed as Chief Executive Officer of Avita Medical Ltd., with effect from 14 April 2015. Mr. Kelliher is a successful entrepreneur with a strong marketing background and a track record of creating and building life science companies. He previously founded Equateq Limited, a cGMPcertified manufacturer providing superpure fatty acids for the nutritional, pharmaceutical and research sectors which was sold to BASF in 2012. He also started Equazen Limited, a leading omega3 and omega6 supplement company whose lead product, eye q for lipid deficiencies linked to learning conditions, and at sale was marketed in 16 countries. Equazen was sold to Galencia of Switzerland in December, 2007
CEO Since 2015Kelliher received a Master of Arts from the University of Auckland and is a graduate of the Entrepreneurial Development Program at the Massachusetts Institute of Technology, Sloan School of Management.